STOCK TITAN

Soleus Capital group (VCEL) discloses 2.8% Vericel ownership under 5% level

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Soleus Capital Master Fund, L.P. and related Soleus entities report beneficial ownership of Vericel Corp common stock on an amended Schedule 13G. They collectively report 1,458,882 shares of Vericel, representing 2.8% of the common stock outstanding, placing them in the category of ownership of 5 percent or less of the class.

All reported voting and dispositive authority over these shares is shared, with no sole power to vote or dispose. The ownership percentage is based on 51,206,614 shares outstanding as of July 24, 2026, as referenced from Vericel’s Form 10-Q. Each Soleus-related entity and Guy Levy disclaim beneficial ownership beyond what is required for Section 13(d) reporting.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 1,458,882 shares Vericel common stock reported by Soleus Capital Master Fund, L.P. and related entities
Percent of class 2.8% Ownership percentage of Vericel common stock reported by the Soleus group
Shares outstanding baseline 51,206,614 shares Vericel common stock outstanding as of July 24, 2026, per Form 10-Q
Shared voting power 1,458,882 shares Number of Vericel shares over which the Soleus group has shared voting power
Sole voting power 0 shares Number of Vericel shares over which the Soleus group has sole voting power
Date of signatures 08/13/2026 Execution date for signatures by Guy Levy on behalf of each reporting person
beneficial ownership financial
"Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power financial
"Shared Voting Power 1,458,882.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 1,458,882.00"
Section 13(d) regulatory
"for the purpose of determining their obligations under Section 13(d) of the Securities Exchange Act"
Ownership of 5 percent or less of a class regulatory
"Item 5. | Ownership of 5 Percent or Less of a Class."

FAQ

What percentage of Vericel Corp (VCEL) does Soleus Capital report owning?

Soleus Capital-affiliated entities report beneficial ownership of 2.8% of Vericel Corp’s common stock. This is based on 1,458,882 shares compared with 51,206,614 shares outstanding as of July 24, 2026, per Vericel’s Form 10-Q.

How many Vericel (VCEL) shares are reported by Soleus Capital on this Schedule 13G/A?

Soleus Capital Master Fund, L.P. and related entities report holding 1,458,882 Vericel common shares. All of these shares are reported with shared voting and shared dispositive power, and no sole voting or dispositive authority.

Is Soleus Capital now below the 5% ownership threshold in Vericel (VCEL)?

Yes. The filing classifies the group’s holdings as ownership of 5 percent or less of Vericel’s common stock. Their reported 2.8% stake falls below the Section 13(d) 5% reporting threshold for larger block holders.

Who are the reporting persons in the Soleus Capital Schedule 13G/A for Vericel (VCEL)?

The reporting persons are Soleus Capital Master Fund, L.P., Soleus Capital, LLC, Soleus Capital Group, LLC, Soleus Capital Management, L.P., Soleus GP, LLC, and Guy Levy. They report the same 1,458,882 Vericel shares with shared authority.

What voting power does Soleus Capital have over its Vericel (VCEL) shares?

The group reports 0 shares with sole voting power and 1,458,882 shares with shared voting power. They also report no sole dispositive power and 1,458,882 shares with shared dispositive power over Vericel stock.

On what share count is Soleus Capital’s Vericel (VCEL) ownership percentage based?

The reported 2.8% ownership is calculated using 51,206,614 Vericel common shares outstanding as of July 24, 2026. That outstanding share figure comes from Vericel’s Form 10-Q for the quarter ended June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





92346J108

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus Capital Master Fund, L.P. ("Master Fund"). Soleus Capital, LLC ("Soleus Capital") is the sole general partner of Master Fund, Soleus Capital Group, LLC ("SCG") is the sole managing member of Soleus Capital, Soleus Capital Management, L.P. ("SCM") is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 51,206,614 shares of the common stock of Vericel Corporation (the "Issuer") outstanding as of July 24, 2026, as reported on the cover of the Issuer's Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026, filed with the Securities and Exchange Commission on July 30, 2026 (the "Form 10-Q").


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 51,206,614 shares of the common stock of the Issuer outstanding as of July 24, 2026, as set forth on the cover of the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 51,206,614 shares of the common stock of the Issuer outstanding as of July 24, 2026, as set forth on the cover of the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 51,206,614 shares of the common stock of the Issuer outstanding as of July 24, 2026, as set forth on the cover of the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 51,206,614 shares of the common stock of the Issuer outstanding as of July 24, 2026, as set forth on the cover of the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons \s the beneficial owner of such shares for any other purpose. (2) The percentage set forth in row 11 is calculated based upon 51,206,614 shares of the common stock of the Issuer outstanding as of July 24, 2026, as set forth on the cover of the Form 10-Q.


SCHEDULE 13G



Soleus Capital Master Fund, L.P.
Signature:/s/ Guy Levy
Name/Title:Guy Levy / Managing Member of the Managing Member of the General Partner of Soleus Capital Master Fund, L.P.
Date:08/13/2026
Soleus Capital, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy / Managing Member of the Managing Member of Soleus Capital, LLC
Date:08/13/2026
Soleus Capital Group, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy / Managing Member
Date:08/13/2026
Soleus Capital Management, L.P.
Signature:/s/ Guy Levy
Name/Title:Guy Levy / Managing Member of the General Partner of Soleus Capital Management, L.P.
Date:08/13/2026
Soleus GP, LLC
Signature:/s/ Guy Levy
Name/Title:Guy Levy/Managing Member
Date:08/13/2026
Guy Levy
Signature:/s/ Guy Levy
Name/Title:Guy Levy
Date:08/13/2026